Company: CDLX
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001666071-25-000126
Chunk: 144

Company: Cardlytics, Inc.
Filing Date: 2025-08-06
Form: 10-Q
Item: Item 1
Chunk 144
---
 (5,808)102 9 Reduction in force1,474 — 1,474 — Adjusted EBITDA$2,703 $(2,285)$(1,681)$(2,059)

31

Adjusted Net Loss

The following table presents a reconciliation of Adjusted Net Loss to Net Loss, the most directly comparable GAAP measure, for each of the periods indicated:

 Three Months EndedJune 30,Six Months EndedJune 30,in thousands2025202420252024Net Loss$(9,283)$(4,257)$(22,565)$(28,532)Plus:Stock-based compensation expense7,501 12,644 16,195 23,629 Foreign currency (gain) loss(5,449)(99)(8,076)531 Gain on debt extinguishment— (13,017)— (13,017)Acquisition, integration and divestiture costs— 162 — 162 Amortization of acquired intangibles1,455 2,785 2,909 5,574 Loss (gain) on disposal or divestiture200 — (5,150)— Change in contingent consideration42 (5,808)102 9 Reduction in force$(1,474)$— $(1,474)$— Adjusted Net Loss$(7,008)$(7,590)$(18,059)$(11,644)Weighted-average number of shares of common stock used in computing Adjusted Net Loss per share:Weighted-average common shares outstanding, diluted52,750 49,056 52,309 46,168 Adjusted Net Loss per share, diluted$(0.13)$(0.15)$(0.35)$(0.25)

Free Cash Flow

The following is a reconciliation of free cash flow to net cash used in operating activities, the most directly comparable GAAP measure, for each of the periods indicated:

Three Months EndedJune 30,Six Months EndedJune 30,in thousands2025202420252024Net cash provided by (used in) operating activities$1,227 $4,430 $(5,481)$(13,188)Plus:Acquisition of property and equipment(322)(281)(441)(932)Capitalized software development costs(4,336)(4,577)(8,320)(8,673)Free Cash Flow$(3,431)$(428